Dr. Taoufik Alsaadi

4 Reviews

About the Doctor

Dr. Taoufik Alsaadi is currently the Chief Medical Officer and Chairman of the neurology department at the American Center for Psychiatry and Neurology. Dr. Alsaadi received his training from the University of California, San Francisco, USA where he was a research fellow in epilepsy. After that, he completed his certifications from the American Board of Neurology, the American Board of Clinical Neurophysiology and the American Board of Psychiatry and Neurology.

In addition to his clinical expertise Dr. Alsaadi was an Associate Professor of Neurology at University of California, Davis, where he was also the Director of the Adult Epilepsy Program and the Clinical Research Program. His main focus is on treatment and management of epilepsy, neuro-behavioral disorders, multiple sclerosis, headaches and neuro-behavioral disorders.


  • Medical Degree, Damascus University, Syria

Specializing In

Neuro-Behavioral Disorders

Chronic Headache Multiple Sclerosis Seizures / Epilepsy
ن.ا: دكتور بجنن ممتاز Sep 19, 2018
Bedside Manner
Wait Time
A.A: طبيب ممتاز علما وخلقا وتعامل مع المرضي. ربنا يجازية خيرا. Dec 13, 2017
Bedside Manner
Wait Time
ط.ك: رائعة جدا Nov 11, 2017
Bedside Manner
Wait Time
M.A: كل شيئ كان موفق Apr 19, 2017
Bedside Manner
Wait Time

Licenses / Permits

  • Dubai Health Authority (DHA)
  • Health Authority of Abu Dhabi - HAAD

Awards & Publications

  • Francis Forster Award, Wisconsin Neurological Society Annual Meeting
  • Scholarship Award, AAN 51st Annual Meeting, Toronto, Ontario, Canada
  • David I.M. Fine Award, for Excellence and Outstanding performance during postgraduate Training
  • Edward E. Shev Award, Western Clinical Neurophysiology Society Annual Meeting
  • Nominated as Best speaker, HAAD
  • Patient’ Choice Award, California
  • Most Compassionate Doctor Award, California
  • Distinguished Chief resident Award
  • Outstanding Teacher Award
  • T. Alsaadi, J. R. Binder, R. M. Lazar, T. Doorani, and J. P. Mohr: “Pure Topographical Disorientation: A Distinctive Syndrome with Varied Localization”. Neurology, 54 (9): 1864-1866.
  • T. Alsaadi, G. L. Morris, and W. Mueller: “Prognostic value of the consistency of lateralizing Ictal features and ictal EEG in patients undergoing temporal lobectomy for refractory complex partial seizures”. Clinical EEG, 32 (2): 87-91.
  • T. Alsaadi, J.L. Ulmer, M.J. Mitchell, G.L. Morris, S. Swanson and W. Mueller: “MR Analysis of Post-surgical Temporal Lobectomies”. Journal of Neuroimaging, 11 (3): 243-247.
  • T. Alsaadi, J.L. Ulmer, M.J. Mitchell, G.L. Morris, S. Swanson and W. Mueller: “MR Analysis of Post-surgical Temporal Lobectomies”. Journal of Neuroimaging, 11 (3): 243-247.
  • T. Alsaadi, N. Barbaro, P. Garcia; and K. D. Laxer: “False lateralization by subdural electrodes in patients with Temporal Lobe epilepsy”. Neurology, 57:532-534.
  • T. Alsaadi, K.D. Laxer, P. Garcia; and N. Barbaro: “Vagus nerve stimulation for the treatment of bilateral independent temporal lobe epilepsy”. Epilepsia, 42 (7): 954-956.
  • R. Neppl, N. Canh, W. Bowen, T. Alsaadi, J. Pallagi, G. Morris, R. Johnson, R. Prost; and S. Rand: “In Vivo Proton MRS Detection of Post-Ictal Perturbations of Cerebral Metabolism”. American Journal of Neuroradiology, 22: (10): 1933-1943.
  • R. Sucholeiki, T. Alsaadi: G. L. Morris, B. Biswal, J. Ulmer; and W Mueller: “fMRI in patients with vagus nerve stimulation”. Seizure, 11 (3): 157-162.
  • T. Alsaadi, C. Thieman; and E. Zusman: “Levetiracetam Monotherapy for adults with localization-related epilepsy”. Epilepsy & Behavior, 3 (5): 471-474.
  • M. Gansaeuer, T. Alsaadi: “Carbamazepine-induced seizures: A case report and review of the literature.” Clinical EEG, 33(4): 174-177.
  • M. Gansaeuer, T. Alsaadi: “Lithium intoxication mimicking clinical and electrographic features of status epilepticus: A case report and review of the literature.” Clinical EEG, 34 (1): 28-31.
  • T. Alsaadi, C. Thieman: “Levetiracetam monotherapy for newly diagnosed epilepsy patients”. Seizure, 12 (3): 154-156.
  • T. Alsaadi, L. Bateman, K.D. Laxer, N.M. Barbaro, E.J. Austin; and P. Garcia:“Potentially misleading extratemporal lobe lesions in patients with temporal lobe epilepsy”. Journal of Neurology, Neurosurgery& Psychiatry, 74 (5): 566-569
  • T. Alsaadi, G. L. Morris, J. Pallagi; and W. Mueller. “Lateralizing value of ictal features in partial seizures: effect on postsurgical outcome”. Seizure, 12 (5): 257-260
  • S. Farias, C. Thieman; and T. Alsaadi. Nonepileptic Seizures: Acute change in event frequency after presentation of the diagnosis. Epilepsy & behavior, 4 (4): 424-429.
  • T. Alsaadi, S. Koopmans, M. Apperson, and S. Farias:” Levetiracetam monotherapy for elderly patients with epilepsy.” Seizure 13 (1): 58-60
  • T. Alsaadi, C. Thieman, A. Shatzel; and S. Farias. "Video EEG telemetry can be a crucial tool for neurologists experienced in epilepsy when diagnosing seizure disorders". Seizure 13 (1): 32-34
  • A. Marquez, S. Koopmans, M. Apperson, S. Farias, A. Lima III, A. Shatzel; and Alsaadi T: Psychogenic Nonepileptic seizures (NES) are associated with an increased risk of obesity. Epilepsy & Behavior 5(1): 88-93
  • S. Richardson, S. Farias, Ph.D., and T. Alsaadi: Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy & Behavior 5(3):343-347.
  • T. Alsaadi, A. Shatzel, A. Lima III, F. Chen, A. Marquez; S. Farias: Clinical experience of Levetiracetam Monothrapy for adults with epilepsy: One-year follow-up study. Seizure 14 (2): 139-142.
  • T. Alsaadi, A. Vinter: Current Understanding of Psychogenic Nonepileptic Seizures. American Family Physicians 72 (5): 849-856.
  • D. Hilty, J. Bourgeois, S. Sugden, C. Chang, M. Servis, and T. Alsaadi: An integrated Neuropsychiatric approach to diagnosis and management of patients presenting with epileptic seizures. Current Treatment Options in Neurology 7: 389-402
  • D. Blum, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 67; 400-406
  • K C. Mills, et al. Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. Epilepsy Research 78: 140—146
  • S. Bohlega, T. Alsaadi, et al. Guidelines for the Pharmacologic Treatment of Neuropathic Pain: Expert Panel Guidelines for the Middle East Region. Journal of International Medical Research 38 (2):1-23
  • T. Alsaadi. “Neuropsychiatric issues in patients with epilepsy: focus on depression”. Therapy 7(5): 507-515
  • B. Yamout, T. Alsaadi, et al. Practice guidelines for the diagnosis and treatment of Multiple Sclerosis. Current Medical Research & Opinion 29 (6), 611–621
  • T. Alsaadi, A. Alkaddour, T. Shahrour, M. Shakra, L. Turkawi, and A. Shatila: Midwakh induced seizures: Case series from UAE. Epilepsy & Behavior 39: 85–87
  • T. Alsaadi, TM Shahrour. Language lateralization in a patient with temporal lobe epilepsy and callosal agenesis. Epilepsy & Behavior Case Reports 3:1-3
  • B. Yamout, T. Alsaadi, et al. Consensus Recommendations for the Diagnosis and Treatment of Multiple sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS). Current Medical Research & Opinion
  • T. Alsaadi, H. Taha, F. Al Hammadi. Choice of Antiepileptic Drugs in Idiopathic Generalized Epilepsy: UAE Experience. Epilepsy Treatment and Research. Article ID 184928, 4 pages
  • T. Alsaadi, M. Shakra, L. Turkawi, J. Hamid. VNS terminating refractory nonconvulsive SE secondary to anti-NMDA encephalitis: A case report. Epilepsy & Behavior Case Reports 3:39–42
  • T. Alsaadi, K. El Hammasi, TM. Shahrour, et al. Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study. Epilepsy & Behavior 52: 194–199
  • T. Alsaadi, K. El Hammasi, TM. Shahrour, et al. Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study. Behavioural Neurology, Article ID 196373, 4 pages
  • T. Alsaadi, K. El Hammasi, TM. Shahrour. Does pyridoxine control behavioral symptoms in adult patients treated with levetiracetam? Case series from UAE. Epilepsy & Behavior Case Reports 4: 94–95
  • M. Alameri, M. Shakra, T. Alsaadi : Fatal Coma in A Young Adult due to Late-Onset Urea Cycle Deficiency presenting with a prolonged seizure: A Case Report Journal: Journal of Medical Case Reports 9:267

Board Certifications

  • American Board of Psychiatry and Neurology
  • American Board of Clinical Neurophysiology
  • American Board of Epilepsy

Professional Memberships

  • Western Clinical Neurophysiology Society
  • American Academy of Neurology, Fellow
  • American Epilepsy Society, Active
  • Vice-President, Commission on Eastern Mediterranean Affairs (CEMA)
  • Faculty, ILAE Education task force
  • President Emirati League against Epilepsy

Languages Spoken

  • Arabic
  • English

American Center for Psychiatry and Neurology - Dubai

Average Price
Consultation Range 600 AED - 700 AED

American Center for Psychiatry and Neurology - Abu Dhabi

Average Price
Consultation Range 600 AED - 700 AED
600 AED - 700 AED